Ticker Details
Carisma Therapeutics, Inc.
IPO Date:	February 3, 2014
Sector:	Healthcare
Industry:	Biotech
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.14 | 6.91%
Avg Daily Range (30 D):	$0.01 | 37.50%
Avg Daily Range (90 D):	$0.01 | 34.26%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.03M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	550
Avg Trade Size (Sh.) (30 D):	3,014
Avg Trade Size (Sh.) (90 D):	2,623

Institutional Trades
Total Institutional Trades:	13
Avg Institutional Trade:	$3.26M
Avg Institutional Trade (30 D):	$.8M
Avg Institutional Trade (90 D):	$.8M
Avg Institutional Trade Volume:	.6M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.58M
Avg Closing Trade (30 D):	$3.25M
Avg Closing Trade (90 D):	$3.25M
Avg Closing Volume:	784.55K

News

Jul 26, 2025 @ 5:47 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 16, 2025 @ 3:32 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire

Jul 15, 2025 @ 12:31 AM $HAREHOLDER ALERT: The M&A Class Action Firm Launc... Source: Juan Monteverde

Jul 5, 2025 @ 1:48 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc

Jul 1, 2025 @ 10:18 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Prnewswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.19	$1.07	$-.23
Diluted EPS	$.19	$1.07	$-.23
Revenue	$52.6M	$45.3M	$M
Gross Profit
Net Income / Loss	$8.04M	$44.72M	$-9.77M
Operating Income / Loss	$10.85M	$43.81M	$-5.78M
Cost of Revenue
Net Cash Flow	$-24.1M	$.78M	$-5.74M
PE Ratio

Splits
Mar 08, 2023	2:1